Revision as of 15:38, 10 January 2012 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Saving copy of the {{chembox}} taken from revid 413451407 of page VM_(nerve_agent) for the Chem/Drugbox validation project (updated: 'CASNo'). |
Latest revision as of 01:22, 12 November 2024 edit Citation bot (talk | contribs)Bots5,424,059 edits Added doi-broken-date. | Use this bot. Report bugs. | #UCB_CommandLine |
Line 1: |
Line 1: |
|
|
{{refimprove|date=March 2018}} |
|
{{ambox | text = This page contains a copy of the infobox ({{tl|chembox}}) taken from revid of page ] with values updated to verified values.}} |
|
|
{{chembox |
|
{{chembox |
|
|
| Verifiedfields = changed |
⚫ |
| verifiedrevid = 402847770 |
|
|
|
| Watchedfields = changed |
⚫ |
| Name = VM (nerve agent) |
|
|
⚫ |
| verifiedrevid = 470627428 |
|
⚫ |
| Name = VM |
|
| ImageFile = VM-2D-skeletal.png |
|
| ImageFile = VM-2D-skeletal.png |
|
| ImageName = Skeletal formula of VM |
|
| ImageName = Skeletal formula of VM |
|
| ImageFile1 = VM-3D-balls.png |
|
| ImageFile1 = VM-3D-balls.png |
|
| ImageName1 = Ball-and-stick model of VM |
|
| ImageName1 = Ball-and-stick model of VM |
|
|
| PIN = ''S''- ''O''-ethyl methylphosphonothioate |
|
| IUPACName = 2-(ethoxy- methylphosphoryl) sulfanyl- N,N-diethylethanamine |
|
|
| Section1 = {{Chembox Identifiers |
|
| Section1 = {{Chembox Identifiers |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
Line 17: |
Line 19: |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey = BKWMHKJLXIRTAI-UHFFFAOYSA-N |
|
| StdInChIKey = BKWMHKJLXIRTAI-UHFFFAOYSA-N |
|
|
| CASNo_Ref = {{cascite|changed|??}} |
|
| CASNo = <!-- blanked - oldvalue: 21770-86-5 --> |
|
| CASNo = 21770-86-5 |
|
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
|
| UNII = 2XM5EU7NUM |
|
| SMILES = O=P(OCC)(SCCN(CC)CC)C |
|
| SMILES = O=P(OCC)(SCCN(CC)CC)C |
|
| PubChem = 30800 |
|
| PubChem = 30800 |
Line 30: |
Line 35: |
|
}} |
|
}} |
|
}} |
|
}} |
|
|
|
|
|
'''VM''' ('''Edemo''') is a "V-series" ] closely related to the better-known ].<ref name="emergency">{{ cite book | last = Burke | first = R. | title = Counter-Terrorism for Emergency Responders | edition = 2nd | year = 2006 | publisher = CRC Press | isbn = 978-0-8493-9923-7 | page = 94 | doi = 10.1201/9781420009903.fmatt | doi-broken-date = 2024-11-12 | url = https://books.google.com/books?id=ZavD-EaJy74C&pg=PA94 }}</ref> |
|
|
|
|
|
Like most of the agents in the V-series (with the exception of VX), VM has not been extensively studied outside of ]. Little is known about this ] other than its ].<ref name="emergency"/> |
|
|
|
|
|
It is commonly theorized that the so-called "second-generation" V series agents came from a ] era ]n ] development program. They may have been developed sometime between 1950 and 1990. They have similar ] levels to VX (between 10 and 50 mg) and have similar ] and ] to other nerve agents that act on ]. The treatment remains the same, but the window for effectively treating second generation V series ]s is shorter. In addition to the standard seizures, some of the second generation V series agents are known to cause ]s.<ref name="emergency"/> |
|
|
|
|
|
==References== |
|
|
{{reflist}} |
|
|
|
|
|
{{Chemical warfare}} |
|
|
{{Acetylcholine metabolism and transport modulators}} |
|
|
|
|
|
] |
|
|
] |
|
|
] |
|
|
] |
|
|
] |
|
|
|
|
|
|
|
|
{{organic-compound-stub}} |